Scott Clarke, Founder of Tizona Therapeutics

Scott Clarke is the founder of Tizona Therapeutics. Tizona Therapeutics has raised $70M in total funding. Latest round: Series D.

About Scott Clarke

Scott Clarke started as CEO of Tizona Therapeutics in January 2019. Previously, he was Global Head of Oncology Partnering and Head of Asia and Emerging Markets Partnering at Roche. He also held roles of increasing responsibility at BioMarin Pharmaceutical, Inc., most recently as Senior Vice President of Product Development.

Scott Clarke at a glance

More founders in South San Francisco, CA, USA (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library